WINDTREE THERAPEUTICS INC /DE/ Stock Issued During Period, Value, Employee Benefit Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- WINDTREE THERAPEUTICS INC /DE/ stock issued during period, value, employee benefit plan for fiscal 2017 was $95.00K, a 65.33% decline from fiscal 2016.
- WINDTREE THERAPEUTICS INC /DE/ stock issued during period, value, employee benefit plan for fiscal 2016 was $274.00K, a 49.17% decline from fiscal 2015.
- WINDTREE THERAPEUTICS INC /DE/ stock issued during period, value, employee benefit plan for fiscal 2015 was $539.00K, a 42.90% decline from fiscal 2014.
- WINDTREE THERAPEUTICS INC /DE/ stock issued during period, value, employee benefit plan for fiscal 2014 was $944.00K, a 1.56% decline from fiscal 2013.
| Period end | Stock Issued During Period, Value, Employee Benefit Plan 3 month | Stock Issued During Period, Value, Employee Benefit Plan 12 month |
|---|---|---|
| 2017-12-31 | $95.00K 10-K/A · filed 2019-04-23 | |
| 2016-12-31 | $274.00K 10-K · filed 2018-04-17 | |
| 2015-12-31 | $539.00K 10-K · filed 2017-03-31 | |
| 2014-12-31 | $944.00K 10-K · filed 2016-03-29 | |
| 2013-12-31 | $959.00K 10-K · filed 2015-03-16 | |
| 2012-12-31 | $763.00K 10-K · filed 2015-03-16 | |
| 2011-12-31 | $497.00K 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |